Filler price by area in Myeongdong runs per 1cc syringe: lips from ₩139,000 (≈ $99), cheeks from ₩139,000 (≈ $99), tear trough from ₩169,000 (≈ $121) — co-director injected at Kind Global Clinic, identical KRW price for international patients.
The useful way to read a filler price by area is as a planning tool, not a list. Each facial zone on the Kind Global Clinic Myeongdong menu carries its own per-1cc price because each zone carries different injection risk, different anatomy and a different product requirement: a structural chin needs a firm gel, mobile lips need a flexible one, and the tear trough needs a low-viscosity product placed by an experienced hand. That is why the filler price by area is not one flat number — and why the gap between zones is information, not noise.
The menu gives every zone a value tier and a premium tier. Korean HA brands price the entry point — lips from ₩139,000 (≈ $99), nasolabial folds from ₩139,000 (≈ $99), forehead from ₩139,000 (≈ $99) — while imported brands price the premium line for the same zones: lips in Juvederm at ₩349,000 (≈ $249), cheeks at ₩349,000 (≈ $249), tear trough in Restylane Eyelight at ₩250,000 (≈ $179). The tier changes the gel, not the injector: every syringe at Kind Global Clinic is placed personally by Dr. Lee Wonjin (KR Medical License 143124) or Dr. Lee Kangin (KR Medical License 141247), never delegated.
Budget sequencing is the part most first-time patients miss. One well-chosen zone usually changes a face more than three thinly spread ones, so the honest plan starts with the zone that drives your concern — midface support before marionette lines, chin projection before jaw refinement — and adds adjacent zones only if the 15-20 minute co-director consultation confirms they still matter after the first correction. Two safety facts complete the picture: HA filler is reversible, with dissolving of filler placed elsewhere published at ₩129,000 (≈ $92), and the KRW price for every area is identical for Korean and international patients, with no broker margin on any published line.